Paricalcitol-d6

• CAT Number: S000550
• CAS Number: 2070009-67-3
• Molecular Formula: C27H38D6O3
• Molecular Weight: 422.67
• Purity: ≥95%
• Target: VD/VDR
• IUPAC Name: (1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(E,2R,5S)-7,7,7-trideuterio-6-hydroxy-5-methyl-6-(trideuteriomethyl)hept-3-en-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol
• InChI: InChI=1S/C27H44O3/c1-18(8-9-19(2)26(3,4)30)24-12-13-25-21(7-6-14-27(24,25)5)11-10-20-15-22(28)17-23(29)16-20/h8-11,18-19,22-25,28-30H,6-7,12-17H2,1-5H3/b9-8+,21-11+/t18-,19+,22-,23-,24-,25+,27-/m1/s1/i3D3,4D3
• InChIKey: BPKAHTKRCLCHEA-OYAGBYDGSA-N
• SMILES: CC(C=CC(C)C(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3)O)O)C

Paricalcitol-d6（Cat No.:S000550） is a specialized form of paricalcitol, a synthetic vitamin D analog used to treat secondary hyperparathyroidism in patients with chronic kidney disease. The “d6” designation indicates that six hydrogen atoms in the paricalcitol molecule are replaced with deuterium, a stable isotope of hydrogen. This isotopic labeling facilitates precise tracking of paricalcitol metabolism and its pharmacokinetics using advanced analytical techniques like mass spectrometry.